Moffitt Cancer Center researchers identify hidden target of ROS1 inhibitor lorlatinib

Pfizer’s Abryso is designed to stimulate an immune response against RSV prefusion conformation (pre-F), thereby providing protection against lower respiratory tract disease caused by RSV.

Cholangiocarcinoma accounts for approximately 3% of all gastrointestinal malignancies. Credit: Explode / Shutterstock.com. Nuvectis Pharma has received orphan drug designation from the US Food and

A spon­sored so­cial me­dia post for Slynd birth con­trol is the lat­est ad of­fend­er in the eyes of the FDA’s pro­mo­tions watch­dog. The Of­fice of